Gardasil CCNI recommended
Administrez-vous le vaccin Gardasil aux jeunes femmes?
Recommand?© par le CCNI pour les filles et les femmes ag?©es de 9 a 26 ans.
Do you administer the Gardasil vaccine to young women?
Recommended by CCNI for girls and women ages 9 to 26 years.

Gardasil (Merck & Co.), also known as Gardisil or Silgard, is a vaccine against certain types of human papillomavirus (HPV).
Gardasil is designed to prevent infection with HPV types 16, 18, 6, and 11. HPV types 16 and 18 that currently cause about 70% of cervical cancer cases, and also cause some vulvar, vaginal, penile and anal cancers. HPV types 6 and 11 cause about 90% of genital warts cases.
Gardasil is only effective in preventing HPV infections, not in treating those already infected by HPV, and so the vaccine must be given before HPV infection occurs in order to be effective. For this reason it is recommended to administer the vaccine before adolescence and the onset of sexual activity.

Brand name: Gardasil
Generic name/category: Vaccines, Papillomavirus
Company: Merck Frosst
Country/Market: Canada, North America
Indication(s)/use: human papillomavirus (HPV) types 6, 11, 16 and 18 infection prevention
Target: Healthcare Professionals (HCP)
Medium: Print ad
Size/duration: single-page
Publication/Aired: Le M?©decin Du Qu?©bec – Septembre 2009
To see all of this brand's ads on AdPharm, click here
0 views
Sep 09, 2009
Visit AdPharm.net for more pharmaceutical ads




